| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.22 | 4e-07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 2e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0003 |